Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-4.62M.
ENTERPRISE VALUE (EV)
$-4.62M
Co-Diagnostics, Inc.
Market Cap
$6.69M
Enterprise Value (EV)
$-4.62M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Co-Diagnostics, Inc. (CODX) | $6.69M | $-4.62M |
| Aclarion, Inc. (ACON)vs › | $6.74M | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.80M | $15.57M |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.49M | N/A |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.43M | $5.95M |
| Biomerica, Inc. (BMRA)vs › | $6.40M | $6.97M |
| Mangoceuticals, Inc. (MGRX)vs › | $6.98M | $7.08M |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.02M | $7.02M |
| Femasys Inc. (FEMY)vs › | $6.24M | $9.58M |
| KALA BIO, Inc. (KALA)vs › | $7.09M | $6.86M |
Market Cap
$6.69M
Total Debt
$574301.00
Cash
$11.88M
Enterprise Value
$-4.62M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
